Description: Presented at October 2001 Annual Meeting. Panelists provide insight into the factors driving the cost increase of prescription drugs and how these factors are being addressed. Strategies include drug utilization review, manufacturer contracting, benefit design, formularies, pharmaceutical pricing, therapeutic substitution, physical education, and introduction of new pharmaceuticals. Also discussed are pharmacoeconomic benefit considerations when studying integrated medical and pharmacy expenses.

Description: Presented at October 2001 Annual Meeting. Explores current and projected Internet trends and how they may change the way the group health and non-medical business operate.

Description: This session 84I of the 2001 SAO Annual Meeting in New Orleans is about how many insurers are migrating toward Web-based interactive underwriting systems in order to economize and streamline the underwriting process. This requires some radically different techniques well beyond the time-honored traditional approaches. From the Record of the Society of Actuaries, Vol 27, No. 3

Description: Panelists review the history of why Medicare has lacked prescription drug coverage and why some of the previous proposals have failed. The session then discusses drug coverage in Medicare Advantage, Medicare Supplemental plans and Part D. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 106pd.

Description: What would we do if we could start pension funding all over? Would we have minimums, maximums, solvency-based contributions, the PBGC? What does financial economics say about how plans ought to be financed? From the Record of the Society of Actuaries, Vol. 30, No. 3.

Description: This 1997 Valuation Actuary Symposium, Session 15 focuses on life modeling.

Description: From an interactive forum session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 This interactive forum addressed the major financial reporting issues and concerns of senior actuaries in life insurance companies.

Description: From a teaching session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Discussion of the actuarial aspects, methods, and considerations of reporting under FAS 60, FAS 97, and FAS 115. Examples and financial statement case studies are included.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000. This session is an overview of FAS 133, accounting for derivatives, and the impact it will have on life companies.

Description: The panel discusses some of the major effects of the Retirement Protection Act of 1994 in areas other than funding. Topics include calculation of lump sums, section 415 limits, creation of the missing participants program, changes in the variable rate premium and elimination of the excise tax for some non deductible contributions. From the Record of the Society of Actuaries, Vol. 21, No. 3a.